Member Log-in

I forgot my password

Not a Member? Register

Transition to Program Budgeting in Health: Experience from Countries and Lessons Learned

WHO’s Department of Health Systems Governance and Financing is providing support to Ministries of Health in this transition process, with the following aims: 1) building the knowledge base on good practices in health budget reforms, including the development of an online health budget portal and country case studies; 2) providing technical support and guidance to countries transitioning to program budgeting in health; 3) capacity development at global and country level. By documenting country experience of budget reforms in the health sector, lessons can be drawn and shared with other countries.

Country case studies presented here document experience with budget reforms from the perspective of the health sector. Specifically, they focus on transition to program budgeting, describing the reform process, motivation for reforms, key actors, progress and remaining challenges. These case studies are unique in linking general budgeting and health financing reforms in the country, identifying the effects of these reforms on alignment of health policy priorities and budgets, prioritization of health expenditures, and shift to output-based provider payment methods.

You May Also Like

Update for Countries and Regional Partners Requesting Gavi Post-transition Support

In November 2017, the Gavi Board approved continued Gavi Alliance engagement with transitioned countries and a budget allocation of up to US$30m to support these countries until 2020. Support is being provided for technical assistance in key programmatic areas, including supply chain, LMC and data, paying special attention to innovative approaches and government commitment to … Continued

Continuing Pneumococcal Vaccination After Gavi Transition in Kenya at Full Price is Cost-effective and Could Save Thousands of Lives

This news release was originally published on EurekAlert. Below is an excerpt from the news release. Co-led by the London School of Hygiene & Tropical Medicine and the KEMRI-Wellcome Trust Research Program, the Pneumococcal Conjugate Vaccine Impact Study estimated that continuing the vaccine beyond 2022 would prevent – in the first ten years – more than … Continued

Choose a Language